AABB participates in a variety of meetings and collaborations:
Meeting Summary between AABB and the European Commission (DG SANTE B4)
AABB and the ISCT have formed a Joint Working Group, as a collaborative effort to identify and facilitate project(s) of common interest to both organizations.
AABB/ISCT Working Group Update - 4/4/19
The Cellular Therapy FDA Liaison Meeting brings together representatives from the cellular therapy community with FDA and other relevant federal government agencies to exchange information on topics of mutual interest.
FDA Liaison Meeting - 12/08/23
FDA Liaison Meeting - 11/15/21
FDA Liaison Meeting - 11/21/19
FDA Liaison Meeting - 3/05/19
FDA Liaison Meeting - 1/30/18
FDA Liaison Meeting - 10/19/16
2018 Center for Biologics Evaluation and Research Science Symposium
Days 1 and 2 videos are available
REGULATORY UPDATE: FDA Issues Draft Guidance to Support CGT Development
November 19, 2024
AABB Accepting Feedback on Cell and Gene Therapy Standards for Pharmacy
November 19, 2024
FDA Approves Direct-to-Brain Gene Therapy for AADC Deficiency
November 14, 2024